Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,014 | -31,315 | -15,925 | -52,673 | -35,231 |
| Depreciation Amortization | 628 | 424 | 212 | 804 | 582 |
| Accounts payable and accrued liabilities | -4,240 | -2,876 | -1,678 | -5,927 | 5,151 |
| Other Working Capital | -3,546 | -2,041 | -1,037 | -3,952 | 4,889 |
| Other Operating Activity | 12,856 | 8,529 | 4,423 | 10,631 | -3,154 |
| Operating Cash Flow | $-40,316 | $-27,279 | $-14,005 | $-51,117 | $-27,763 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 15,925 | N/A |
| PPE Investments | -37 | -31 | -18 | -52 | -37 |
| Investing Cash Flow | $-37 | $-31 | $-18 | $15,873 | $-37 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 6,000 | 6,000 |
| Common Stock Issued | N/A | N/A | N/A | 58,881 | N/A |
| Other Financing Activity | -77 | -77 | -77 | 51,248 | -117 |
| Financing Cash Flow | $-77 | $-77 | $-77 | $116,129 | $5,883 |
| Beginning Cash Position | 110,761 | 110,761 | 110,761 | 29,876 | 29,876 |
| End Cash Position | 70,331 | 83,374 | 96,661 | 110,761 | 7,959 |
| Net Cash Flow | $-40,430 | $-27,387 | $-14,100 | $80,885 | $-21,917 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,316 | -27,279 | -14,005 | -51,117 | -27,763 |
| Capital Expenditure | -37 | -31 | -18 | -52 | -37 |
| Free Cash Flow | -40,353 | -27,310 | -14,023 | -51,169 | -27,800 |